18F-mFBG PET Imaging in the Evaluation of Neuroblastoma
NCT06852807 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2025-08-08
Summary
The aim of this study is to evaluate the diagnostic performance and tumor burden of 18F-metafluorobenzylguanidine (18F-MFBG) positron emission tomography (PET) in patients with neuroblastoma.
Conditions
Interventions
- DRUG
-
18F-MFBG
Patients with neuroblastoma malignancies receive 5.55 MBq/kg of 18F-MFBG intravenously followed by PET/CT or PET/MR after 60min of injection.
Sponsors & Collaborators
-
First Affiliated Hospital of Zhejiang University
lead OTHER
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-02-04
- Primary Completion
- 2027-12-31
- Completion
- 2029-12-31
Countries
- China
Study Locations
More Related Trials
-
124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study
NCT01583842 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Comparison of 18F Labeled Analog of MIBG (18F-MFBG) PET/CT and 123I-MIBG SPECT in Pediatric Patients With Neuroblastoma.
NCT07111117 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
A Phase I/II Study of [124I]mIBG PET/CT in Neuroblastoma
NCT02043899 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
68Ga-DOTA-F2 PET/CT in Patients With Various Types of Cancer
NCT05637034 ·Status: UNKNOWN ·Phase: NA
-
FAP PET/CT or PET/MR Production in the Diagnosis, Staging, and Efficacy Assessment of Malignant Tumors Application
NCT06270394 ·Status: COMPLETED ·Phase: NA
-
68Ga-labeled NY105 PET Imaging in Patients
NCT05691881 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
18F-FAPI-04 PET/CT and PET/MR in Patients With Various Types of Malignant Tumors
NCT06557590 ·Status: RECRUITING
-
18F-FAPI PET/CT in Patients With Various Types of Cancer
NCT05810324 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of 18F-dopa and 123I-MIBG Uptake in the Patients With Neuroblastoma
NCT01943097 ·Status: UNKNOWN
-
68Ga-NOTA-NFB: Radiation Dosimetry in Healthy Volunteers and Applications in Glioma Patients or Breast Cancer Patients
NCT02327442 ·Status: UNKNOWN
-
Clinical Study of 18F -FAPI-RGD in Renal Tumor
NCT05976607 ·Status: COMPLETED
-
Diagnostic Efficacy and Prognostic Value of 18F-FDG PET/CT (MR) in Pediatric Solid Blastoma
NCT06190574 ·Status: COMPLETED
-
Open-Label Study of 18F-mFBG for Imaging Neuroblastoma
NCT04724369 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Fluoroglutamine PET/CT in Imaging Patients With Malignant Tumor
NCT03721055 ·Status: UNKNOWN ·Phase: NA
-
18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors
NCT04258592 ·Status: TERMINATED ·Phase: PHASE1
-
18F-Pentixafor PET in Hematologic Malignancies
NCT07122674 ·Status: RECRUITING
-
18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma
NCT03541720 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Monitor Response to Treatment in Neuroblastoma Using 3&Apos;-Deoxy-3&Apos;-Fluorothymidine- Positron Emission Tomography (FLT-PET)
NCT01308905 ·Status: UNKNOWN ·Phase: NA
-
18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
NCT04813705 ·Status: RECRUITING ·Phase: PHASE2
-
68Ga-N188 PET/CT Imaging in Malignancy
NCT05593107 ·Status: RECRUITING ·Phase: NA
-
18F-AlF-NOTA-Octreotide PET in Neuroendocrine Neoplasms
NCT07102056 ·Status: NOT_YET_RECRUITING
-
PET Image Exploration of Novel Tracer [68Ga]-FAPI-JNU Imaging Studies in Patients with Malignant Tumors
NCT06684028 ·Status: RECRUITING ·Phase: NA
-
Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection
NCT06206642 ·Status: COMPLETED ·Phase: NA
-
Efficacy of 68Ga-Pentixafor PET/MR in Detecting Non-Hodgkin Lymphoma and Multiple Myeloma Lesions
NCT06720207 ·Status: NOT_YET_RECRUITING
-
68Ga-BNU-PSMA PET/CT in Patients With Various Types of Cancer
NCT04525612 ·Status: UNKNOWN ·Phase: EARLY_PHASE1